Salarius Pharmaceuticals Inc (SLRX)

03:17 AM

Can Salarius Pharmaceuticals Inc. (FP10) stock resist broad market declinesTrend Reversal & Accurate Entry/Exit Alerts - Newser

03:17 AM

02:51 AM

Why Salarius Pharmaceuticals Inc. stock is a must watch in 2025Weekly Market Summary & Fast Entry High Yield Tips - Newser

02:51 AM

12:49 PM

Salarius Pharmaceuticals Inc. (SLRX) Stock Price | Live Quotes & Charts | NASDAQ - StocksToTrade

12:49 PM

Dec 04, 2025

Is Salarius Pharmaceuticals Inc. stock attractive for income investorsProduct Launch & Daily Entry Point Alerts - Newser

Dec 04, 2025

Dec 04, 2025

Can Salarius Pharmaceuticals Inc. (FP10) stock sustain breakout momentumJuly 2025 Reactions & AI Powered Market Entry Ideas - Newser

Dec 04, 2025

Dec 02, 2025

How Salarius Pharmaceuticals Inc. (FP10) stock responds to job market shiftsWeekly Volume Report & Smart Money Movement Alerts - Newser

Dec 02, 2025

Dec 01, 2025

Salarius Pharmaceuticals, Inc. (SLRX) 7.9% in After-hours: Collaboration with Texas Biomedical Research Institute Sparks Interest - Stocks Telegraph

Dec 01, 2025

Dec 01, 2025

Salarius Pharmaceuticals' Decoy Unit Partners With Texas Biomed on Flu Inhibitor Testing - MarketScreener

Dec 01, 2025

Dec 01, 2025

Salarius Pharmaceuticals to collaborate with Texas Biomedical Research Institute on avian flu study - marketscreener.com

Dec 01, 2025

Dec 01, 2025

SLRX Collaborates with Texas Research Institute for Influenza Te - GuruFocus

Dec 01, 2025

Dec 01, 2025

Salarius Pharmaceuticals to Collaborate with Texas Biomedical Research Institute on Avian Flu Study - GlobeNewswire

Dec 01, 2025

Nov 28, 2025

Will Salarius Pharmaceuticals Inc. stock benefit from infrastructure spending2025 Trade Ideas & AI Forecasted Entry and Exit Points - moha.gov.vn

Nov 28, 2025

Nov 27, 2025

Is Salarius Pharmaceuticals Inc. stock affected by interest rate hikes2025 Price Action Summary & Consistent Profit Trading Strategies - moha.gov.vn

Nov 27, 2025

Nov 24, 2025

Hanish of Salarius Pharma buys $3740 in shares By Investing.com - Investing.com South Africa

Nov 24, 2025

Nov 24, 2025

Hanish of Salarius Pharma buys $3740 in shares - Investing.com India

Nov 24, 2025

Nov 24, 2025

[Form 4] Salarius Pharmaceuticals, Inc. Insider Trading Activity - Stock Titan

Nov 24, 2025

Nov 24, 2025

What analysts say about Salarius Pharmaceuticals Inc stockDividend Yield Trends & Technical + Fundamental = Smarter Investing - earlytimes.in

Nov 24, 2025

Nov 24, 2025

Salarius Pharmaceuticals Inc (SLRX) can make a big difference with a little luck - Setenews

Nov 24, 2025

Nov 24, 2025

[Form 3] Salarius Pharmaceuticals, Inc. Initial Statement of Beneficial Ownership - Stock Titan

Nov 24, 2025

Nov 21, 2025

SLRX Stock Institutional Owners - Quiver Quantitative

Nov 21, 2025

Nov 21, 2025

How Salarius Pharmaceuticals Inc. stock reacts to inflationary pressuresJuly 2025 PostEarnings & Free AI Powered Buy and Sell Recommendations - newser.com

Nov 21, 2025

Nov 20, 2025

Salarius Pharmaceuticals Exec VP Finance, CFO Mark J Rosenblum Acquires 20,000 Shares - TradingView

Nov 20, 2025

Nov 20, 2025

Salarius Pharmaceuticals Cites Errors on S&P CapIQ Platform Following Merger with Decoy Therapeutics, Affirms Its Shares Continue to Trade on the Nasdaq Stock Market Under the Symbol SLRX - MarketScreener

Nov 20, 2025

Nov 20, 2025

Why Salarius Pharmaceuticals Inc. (FP10) stock stays resilientJuly 2025 Intraday Action & AI Enhanced Market Trend Forecasts - newser.com

Nov 20, 2025

Nov 20, 2025

Salarius clarifies Nasdaq listing status, refutes S&P CapIQ error By Investing.com - Investing.com India

Nov 20, 2025

Nov 20, 2025

Salarius Pharmaceuticals (NASDAQ:SLRX) Stock Price Down 8.3% – Here’s Why - Defense World

Nov 20, 2025

Nov 20, 2025

Will Salarius Pharmaceuticals Inc. (FP10) stock benefit from infrastructure bill - newser.com

Nov 20, 2025

Nov 19, 2025

Ranking Salarius Pharmaceuticals Inc. among high performing stocks via toolsProduct Launch & Stepwise Entry/Exit Trade Alerts - newser.com

Nov 19, 2025

Nov 19, 2025

When is the best time to exit Salarius Pharmaceuticals Inc.Market Trend Summary & Free Weekly Watchlist of Top Performers - newser.com

Nov 19, 2025

Nov 19, 2025

What catalysts could drive Salarius Pharmaceuticals Inc. stock higher - newser.com

Nov 19, 2025

Nov 19, 2025

Applying Elliott Wave Theory to Salarius Pharmaceuticals Inc.Portfolio Profit Report & Low Risk Profit Maximizing Plans - newser.com

Nov 19, 2025

Nov 19, 2025

[8-K] Salarius Pharmaceuticals, Inc. Reports Material Event | SLRX SEC FilingForm 8-K - Stock Titan

Nov 19, 2025

Nov 19, 2025

Salarius Pharmaceuticals Says S&P Capital IQ Platform Misreported Nasdaq Status After Merger - marketscreener.com

Nov 19, 2025

Nov 19, 2025

Salarius Pharmaceuticals (SLRX) Maintains Nasdaq Listing Despite Reporting Error - GuruFocus

Nov 19, 2025

Nov 19, 2025

Salarius clarifies Nasdaq listing status, refutes S&P CapIQ error - Investing.com

Nov 19, 2025

Nov 19, 2025

Trend analysis for Salarius Pharmaceuticals Inc. this weekWeekly Risk Report & Advanced Swing Trade Entry Plans - newser.com

Nov 19, 2025

Nov 19, 2025

Salarius Pharmaceuticals Cites Errors on S&P CapIQ Platform Following Merger with Decoy Therapeutics, Affirms Its Shares Continue to Trade on the Nasdaq Stock Market Under the Symbol 'SLRX” - The Manila Times

Nov 19, 2025

Nov 19, 2025

Salarius Pharmaceuticals Cites Errors on S&P CapIQ Platform Following Merger with Decoy Therapeutics, Affirms Its Shares Continue to Trade on the Nasdaq Stock Market Under the Symbol “SLRX” - marketscreener.com

Nov 19, 2025

Nov 19, 2025

Salarius Pharmaceuticals Cites Errors on S&P CapIQ Platform - GlobeNewswire

Nov 19, 2025